pubmed-article:20233915 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20233915 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20233915 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
pubmed-article:20233915 | lifeskim:mentions | umls-concept:C0024117 | lld:lifeskim |
pubmed-article:20233915 | lifeskim:mentions | umls-concept:C0001617 | lld:lifeskim |
pubmed-article:20233915 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
pubmed-article:20233915 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
pubmed-article:20233915 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:20233915 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:20233915 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:20233915 | pubmed:dateCreated | 2010-3-25 | lld:pubmed |
pubmed-article:20233915 | pubmed:abstractText | The benefits of inhaled corticosteroids (ICS) in reducing the mortality related to chronic obstructive pulmonary disease (COPD) are controversial. | lld:pubmed |
pubmed-article:20233915 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20233915 | pubmed:language | eng | lld:pubmed |
pubmed-article:20233915 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20233915 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20233915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20233915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20233915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20233915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20233915 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20233915 | pubmed:month | Apr | lld:pubmed |
pubmed-article:20233915 | pubmed:issn | 1542-6270 | lld:pubmed |
pubmed-article:20233915 | pubmed:author | pubmed-author:BlaisLucieL | lld:pubmed |
pubmed-article:20233915 | pubmed:author | pubmed-author:AaronShawn... | lld:pubmed |
pubmed-article:20233915 | pubmed:author | pubmed-author:LemièreCather... | lld:pubmed |
pubmed-article:20233915 | pubmed:author | pubmed-author:BeauchesneMar... | lld:pubmed |
pubmed-article:20233915 | pubmed:author | pubmed-author:CyrMarie-Chri... | lld:pubmed |
pubmed-article:20233915 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20233915 | pubmed:volume | 44 | lld:pubmed |
pubmed-article:20233915 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20233915 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20233915 | pubmed:pagination | 613-22 | lld:pubmed |
pubmed-article:20233915 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:meshHeading | pubmed-meshheading:20233915... | lld:pubmed |
pubmed-article:20233915 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20233915 | pubmed:articleTitle | Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. | lld:pubmed |
pubmed-article:20233915 | pubmed:affiliation | Université de Montréal, Québec, Canada. | lld:pubmed |
pubmed-article:20233915 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20233915 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:20233915 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |